What happens when you take fisetin with quercetin?
Fisetin and quercetin are closely related flavonols found in fruits and vegetables (strawberries, apples, onions, capers). Both have antioxidant and anti-inflammatory activity, but in the longevity world they are best known as senolytics: compounds that selectively kill or clear 'senescent' cells, the dysfunctional non-dividing cells that accumulate with age and secrete inflammatory factors (the senescence-associated secretory phenotype, or SASP).
A 2018 screen from the Mayo Clinic group, published in EBioMedicine, identified fisetin as the most potent natural senolytic among ten flavonoids tested. Quercetin showed weaker stand-alone senolytic activity but is the natural compound paired with dasatinib in the most-studied clinical senolytic protocol (D+Q). The mechanisms overlap (modulating BCL-2 family anti-apoptotic proteins in senescent cells, scavenging radicals, inhibiting NF-kB) but are not identical. Combining them in a regimen broadens the targets covered.
Why is this important?
Senescent cell accumulation has been linked to age-related declines in tissue function, frailty, and chronic inflammation. Clearing them in animal models has extended healthspan and improved physical function. The dasatinib + quercetin protocol has been tested in small human trials for diabetic kidney disease, idiopathic pulmonary fibrosis, and post-menopausal bone health, with mixed but promising results.
Most consumers are not going to take dasatinib (a prescription chemotherapy). Natural-only stacks built around fisetin and quercetin are the most common consumer-facing approximation of the senolytic concept. The synergy claim is that fisetin handles potent senolytic 'pulses' while quercetin provides daily anti-inflammatory and antioxidant background coverage. The clinical evidence for the specific fisetin + quercetin pairing is preliminary and largely extrapolated from animal data, so expectations should be calibrated accordingly.
What should you do?
The most common framework is daily quercetin (250-500 mg) for steady antioxidant and anti-inflammatory support, plus intermittent fisetin pulses (500-1,000 mg for 2-3 consecutive days, once per month) for senolytic intent. Pulse dosing mirrors the protocols used in animal senolytic studies, which typically use intermittent rather than continuous administration. Both flavonoids absorb better with fat, so take them with a meal.
People on blood-thinners should be cautious, since both flavonoids can modestly inhibit platelet aggregation and affect cytochrome P450 metabolism of some drugs (including warfarin, certain statins, and many CYP3A4 substrates). Quercetin can transiently raise serum levels of cyclosporine and similar drugs. Anyone on chronic medications should clear the pulse-dose protocol with their clinician first.
Which specific products are affected?
Fisetin is sold as standalone capsules (typically 100-500 mg) and in 'liposomal' formulations that improve absorption. Quercetin is widely available as quercetin dihydrate, with bromelain or vitamin C added for absorption and synergy. Senolytic blends often combine fisetin, quercetin, and resveratrol in a single capsule, though pulse-dosing the fisetin component separately is generally preferred.
- Standalone fisetin (100-500 mg)
- Liposomal fisetin formulations
- Quercetin dihydrate (250-500 mg)
- Quercetin phytosome (Quercefit)
- Senolytic blends (fisetin + quercetin + resveratrol)
The bottom line
Fisetin and quercetin are mechanistically related flavonoids with overlapping but distinct senolytic and anti-inflammatory effects. A reasonable longevity-leaning approach is daily quercetin plus monthly fisetin pulses, taken with fat for absorption. Robust human evidence for the specific combination is limited, so expectations should be modest and prescription-drug interactions checked carefully.